These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 18782562)

  • 21. Systemic lipopolysaccharide plus MPTP as a model of dopamine loss and gait instability in C57Bl/6J mice.
    Byler SL; Boehm GW; Karp JD; Kohman RA; Tarr AJ; Schallert T; Barth TM
    Behav Brain Res; 2009 Mar; 198(2):434-9. PubMed ID: 19070633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased striatal levels of PEP-19 following MPTP lesion in the mouse.
    Sköld K; Svensson M; Nilsson A; Zhang X; Nydahl K; Caprioli RM; Svenningsson P; Andrén PE
    J Proteome Res; 2006 Feb; 5(2):262-9. PubMed ID: 16457591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Taurine fails to protect against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced striatal dopamine depletion in mice.
    Navneet AK; Appukuttan TA; Pandey M; Mohanakumar KP
    Amino Acids; 2008 Aug; 35(2):457-61. PubMed ID: 17701098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alpha-synuclein and its role in metal binding: relevance to Parkinson's disease.
    Wright JA; Brown DR
    J Neurosci Res; 2008 Feb; 86(3):496-503. PubMed ID: 17705291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased dopaminergic neuron sensitivity to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in transgenic mice expressing mutant A53T alpha-synuclein.
    Yu WH; Matsuoka Y; Sziráki I; Hashim A; Lafrancois J; Sershen H; Duff KE
    Neurochem Res; 2008 May; 33(5):902-11. PubMed ID: 17999181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MPTP- but not methamphetamine-induced parkinsonism extends to catecholamine neurons in the gut.
    Natale G; Kastsiuchenka O; Pasquali L; Ruggieri S; Paparelli A; Fornai F
    Ann N Y Acad Sci; 2008 Oct; 1139():345-9. PubMed ID: 18991880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Behavior, neurotransmitters and inflammation in three regimens of the MPTP mouse model of Parkinson's disease.
    Luchtman DW; Shao D; Song C
    Physiol Behav; 2009 Aug; 98(1-2):130-8. PubMed ID: 19410592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of nuclear transcription factor kappa B (NF-kappaB) for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine)-induced apoptosis in nigral neurons of mice.
    Aoki E; Yano R; Yokoyama H; Kato H; Araki T
    Exp Mol Pathol; 2009 Feb; 86(1):57-64. PubMed ID: 19027004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced susceptibility to MPTP neurotoxicity in magnesium-deficient C57BL/6N mice.
    Muroyama A; Inaka M; Matsushima H; Sugino H; Marunaka Y; Mitsumoto Y
    Neurosci Res; 2009 Jan; 63(1):72-5. PubMed ID: 18977253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Striatal extracellular dopamine levels and behavioural reversal in MPTP-lesioned mice.
    Kirchhoff J; Mørk A; Brennum LT; Sager TN
    Neuroreport; 2009 Mar; 20(5):482-6. PubMed ID: 19262413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in adult olfactory bulb neurogenesis in mice expressing the A30P mutant form of alpha-synuclein.
    Marxreiter F; Nuber S; Kandasamy M; Klucken J; Aigner R; Burgmayer R; Couillard-Despres S; Riess O; Winkler J; Winner B
    Eur J Neurosci; 2009 Mar; 29(5):879-90. PubMed ID: 19291219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuropathological changes induced by neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in male Swiss albino mice.
    Rajeswari A; Sabesan M
    Toxicol Ind Health; 2008 Apr; 24(3):189-94. PubMed ID: 18842698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein.
    Fornai F; Schlüter OM; Lenzi P; Gesi M; Ruffoli R; Ferrucci M; Lazzeri G; Busceti CL; Pontarelli F; Battaglia G; Pellegrini A; Nicoletti F; Ruggieri S; Paparelli A; Südhof TC
    Proc Natl Acad Sci U S A; 2005 Mar; 102(9):3413-8. PubMed ID: 15716361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of MPTP on the activation of microglia/astrocytes and cytokine/chemokine levels in different mice strains.
    Yasuda Y; Shimoda T; Uno K; Tateishi N; Furuya S; Yagi K; Suzuki K; Fujita S
    J Neuroimmunol; 2008 Nov; 204(1-2):43-51. PubMed ID: 18817984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fucoidan protects against dopaminergic neuron death in vivo and in vitro.
    Luo D; Zhang Q; Wang H; Cui Y; Sun Z; Yang J; Zheng Y; Jia J; Yu F; Wang X; Wang X
    Eur J Pharmacol; 2009 Sep; 617(1-3):33-40. PubMed ID: 19545563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alpha-synuclein knockdown attenuates MPP+ induced mitochondrial dysfunction of SH-SY5Y cells.
    Wu F; Poon WS; Lu G; Wang A; Meng H; Feng L; Li Z; Liu S
    Brain Res; 2009 Oct; 1292():173-9. PubMed ID: 19646423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased inflammation and augmented expression of trophic factors correlate with MOG-induced neuroprotection of the injured nigrostriatal system in the murine MPTP model of Parkinson's disease.
    Kurkowska-Jastrzebska I; Bałkowiec-Iskra E; Ciesielska A; Joniec I; Cudna A; Zaremba MM; Członkowski A; Członkowska A
    Int Immunopharmacol; 2009 Jun; 9(6):781-91. PubMed ID: 19286483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroprotective effect of L-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson's disease: a direct comparison study.
    Shin JY; Park HJ; Ahn YH; Lee PH
    J Neurochem; 2009 Nov; 111(4):1042-50. PubMed ID: 19765187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine D2 receptor knockout mice develop features of Parkinson disease.
    Tinsley RB; Bye CR; Parish CL; Tziotis-Vais A; George S; Culvenor JG; Li QX; Masters CL; Finkelstein DI; Horne MK
    Ann Neurol; 2009 Oct; 66(4):472-84. PubMed ID: 19847912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of p38 MAPK in the substantia nigra leads to nuclear translocation of NF-kappaB in MPTP-treated mice: implication in Parkinson's disease.
    Karunakaran S; Ravindranath V
    J Neurochem; 2009 Jun; 109(6):1791-9. PubMed ID: 19457134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.